Section II Clinical Guidelines for the Use of Zidovudine therapy in Pregnancy to Reduce Perinatal Transmission of HIV Introduction Identification of Pregnant Women with HIV Infection and Documentation of Maternal HIV Antibody Status Guidelines for the Administration of ZDV for the Prevention of Mother to Child HIV Transmission Guidelines for Antiretroviral Therapy for the Interruption of Mother to Chld HIV Transmission in Pregnant Women with HIV Infection Who Have Not Received Prior Antiretroviral Therapy Important Elements to Include in a Risk/Benefit Discussion of Antiretroviral Therapy to Prevent Mother to Child HIV Transmission Recommendations for Monitoring of Antiretroviral Therapy Program Implementation/Coordination of Health Care Services Conclusion-Summary of Clinical Guidelines References
Table of Contents Section I Section II